| | DRUG: Influenza virus vaccine | |
Entry |
|
Name |
Influenza virus vaccine (USP); FluShield (TN); Fluarix quadrivalent (TN) |
Product |
AFLURIA QUADRIVALENT (Seqirus PTY), FLUAD QUADRIVALENT (Seqirus), FLUARIX QUADRIVALENT (GlaxoSmithKline Biologicals SA), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur), FLUCELVAX QUADRIVALENT (Seqirus), FLULAVAL QUADRIVALENT (ID Biomedical Corporation of Quebec), FLUZONE HIGH DOSE NORTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE HIGH-DOSE (Sanofi Pasteur), FLUZONE HIGH-DOSE QUADRIVALENT SOUTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE NORTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE (Sanofi Pasteur) |
Remark |
Product (DG00674): | D04536<US> D05182<JP> |
|
Efficacy |
Active immunization (influenza virus) |
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BB Influenza vaccines
J07BB01 Influenza, inactivated, whole virus
D04536 Influenza virus vaccine (USP) <US>
|
Other DBs |
|
LinkDB |
|
|
» Japanese version » Back
|